The Popularity of CBD
CBD (cannabidiol) is taking over the wellness market due to its natural benefits, but one question often arises: is it legal? 🌿 The answer depends on the THC (tetrahydrocannabinol) content and the regulations of each country.
In this article, we’ll explore the legality of CBD in Italy and Europe, focusing on THC limits, permitted products, and the differences between full-spectrum, broad-spectrum, and isolates.
1. CBD Legality in Italy
CBD in Italy: Rules, Challenges, and (Too Much) Bureaucracy
In Italy, the legality of CBD depends on the THC content and the type of product:
CBD Flowers (Cannabis Light):
THC Limit: Up to 0.5% is allowed for commercialization.
Farmer Tolerance: Up to 0.6% for natural variations.
CBD Extracts and Oils:
THC Limit: Must be below 0.2% to comply with regulations.
Note: CBD flowers are sold for "technical use" or collection purposes, but many people use them personally due to their compliance with legal THC limits.
Medical Use of THC in Italy:
THC is legal only for medical use and with a prescription, as in the case of medical cannabis.
1.2 CBD: New Legal Challenges in Italy
In recent years, the Italian Ministry of Health has launched a series of controversial initiatives regarding CBD regulation, sparking strong reactions from associations, industry professionals, and courts.
The 2023 Decree and the Lazio Regional Administrative Court Ruling
On August 5, 2023, the Ministry of Health attempted to limit CBD trade by proposing stricter regulations, citing alleged public health risks. However, the World Health Organization (WHO) has already declared CBD safe and non-addictive. On October 25, 2023, the Lazio Regional Administrative Court (TAR) suspended the decree’s enforcement, stating insufficient scientific evidence to support the measure.
The 2024 Decree: New Attempts, Same Criticisms
On July 10, 2024, the Ministry tried again to include oral CBD compositions in the Table of Narcotic Drugs (Section B), limiting their distribution to pharmacies and requiring a non-repeatable medical prescription, thus excluding free trade of these products. The official justification? Preventing unspecified public health risks. This proposal once again sparked strong opposition, and on September 10, 2024, the TAR suspended the decree again, emphasizing that CBD is widely considered safe and non-psychoactive.
1.3 The Future of Cannabis Light: Toward New Restrictions
Did you know that Italy, in the early 1900s, was one of the world’s largest hemp producers? Our varieties were highly regarded for their quality and versatility. Today, cannabis light represents an opportunity to revive this tradition.
In 2024, the Chamber of Deputies approved a bill aiming to ban the sale and commercialization of cannabis light flowers, despite compliance with current THC limits. This proposal, now under discussion in the Senate, has sparked a wave of controversy and criticism from both industry stakeholders and civil society.
An Attack on the Industry and Freedom of Choice
If passed, this legislation would deal a devastating blow to a rapidly growing sector that has:
Created thousands of jobs.
Revitalized previously unused farmland.
Offered consumers a safe and legal alternative.
The ban on cannabis light flowers risks:
Driving consumers to the black market, exposing them to risks associated with unregulated products.
Undermining a market that has proven to be safe and transparent, thanks to rigorous laboratory controls.
The Reasons Behind the Ban
Proponents of the law argue that CBD flowers could easily be mistaken for high-THC cannabis, fueling an illicit market. However, this stance ignores the role of laboratory analyses and quality controls already in place to ensure safety and transparency.
Moreover, the restriction:
Contradicts the more open policies adopted by other European countries.
Risks isolating Italy from the EU market, compromising economic and commercial opportunities.
Growing Resistance
The Senate debate will be crucial for the future of cannabis light in Italy. A responsible and progressive regulation could ensure:
Safety for consumers.
Economic growth for the agricultural and production sectors.
Stable employment for thousands of workers.
Conversely, a ban risks:
Undoing years of regulatory and scientific progress.
Letting misinformation and prohibitionism prevail.
Industry associations, farmers, and consumers are carrying out campaigns to raise public awareness and oppose the ban. Cannabis light, with its low THC content, remains a safe and natural resource, offering benefits without risks to public health.
1.4 Regulatory Impacts: Prohibitionism vs. Progress
Regulatory developments in Italy reflect a broader conflict between prohibitionism and progress. Treating CBD as THC is a huge mistake! It disregards scientific evidence and hinders a market full of opportunities: more jobs, more innovation, and more well-being. Cannabis light is not a threat—it is an economic and environmental resource.
The European Perspective: An Inclusive Model
Regulatory tensions in Italy contrast with some decisions by the European Court of Justice. In 2020, ruling C-663/18 already established that CBD cannot be classified as a narcotic, as it has no psychoactive effects. The Court also reaffirmed the right to cross-border trade: any product legally manufactured in an EU member state cannot be banned in other member states unless there is scientific evidence of a real risk to public health. These decisions exemplify inclusive regulation, in stark contrast to Italy’s proposed restrictions.
Looking Ahead
Since 2023, Regulation (EU) 2021/2115 has standardized the maximum THC limit for industrial hemp at 0.3%, pushing toward harmonized regulation. Countries like the Czech Republic and Switzerland demonstrate how permissive policies can promote safety, innovation, and economic growth, while Italy’s approach risks isolating the country from the European market.
As Europe moves toward clearer and more inclusive regulation, it is crucial for Italy to align with these standards, recognizing CBD as a safe and accessible product, rather than a substance to be feared. Promoting clear and progressive regulation ensures consumer safety and support for the agricultural sector.
2. The Legality of CBD in Europe
Updated European Regulations
The maximum THC limit for industrial hemp has been standardized across Europe at 0.3% under Regulation (EU) 2021/2115, effective from January 1, 2023. However, each country may set different limits for the sale and consumption of CBD products:
Countries with a THC Limit of 0.2%:
Spain, Germany, Slovenia, Poland, and Hungary.
CBD is legal if the THC content remains below 0.2%.
Countries with a THC Limit of 0.3%:
France, Austria, Czech Republic, Luxembourg.
These countries adhere to the new European limit.
Countries with a THC Limit of 0.5%:
Netherlands.
The most permissive limit for industrial hemp and its derivatives.
Countries with a THC Limit of 1%:
Switzerland: Although not part of the EU, Switzerland allows CBD products with up to 1% THC, influencing the European market.
Fun Fact: The Czech Republic recently approved raising the THC limit to 1% for industrial hemp, making it one of the most permissive countries.
| Country | THC Limit | Notes |
|---|---|---|
| Italy | 0.2% (processed products), 0.5% (flowers) | Legal sales within THC limits, but human use is unregulated. Laws under review. |
| France | 0.3% | Sale and consumption of legal CBD flowers with THC content under 0.3%. |
| Germany | 0.2% | CBD is legal for personal and industrial use. |
| Austria | 0.3% | Follows the new European limits. |
| Switzerland | 1% | Independent regulations outside the EU. |
| Czech Republic | 1% | Among the most permissive countries. |
3. Types of CBD Products and Regulations
1. Full-Spectrum CBD:
Includes all cannabinoids and terpenes from the plant, including THC (within legal limits).
Benefits: Entourage effect for enhanced benefits.
Regulations: Legal if THC limits are respected in the country.
2. Broad-Spectrum CBD:
Includes all cannabinoids and terpenes but excludes THC.
Benefits: Similar to full spectrum, without the risk of THC presence.
Regulations: Completely legal.
3. CBD Isolate:
Pure CBD at 99%, free of THC and other cannabinoids.
Benefits: Ideal for those seeking only CBD effects.
Regulations: Always legal due to the absence of THC.
4. What Changes for Consumers?
In Italy:
You can purchase CBD oils, capsules, teas, and flowers, provided they comply with THC limits. Always ensure products are certified and meet Italian regulations.
In Europe:
You can travel with CBD products, but ensure they comply with the THC limits of your destination country. For example, a product legal in Switzerland may not be legal in France.
5. Challenges in Regulation
Lack of Uniformity
Regulations vary from country to country, causing confusion for both consumers and producers.
Toward Unified Regulation
The EU is working to harmonize CBD laws, simplifying cross-border trade.
Conclusion
CBD is legal in Italy and many European countries, as long as it complies with THC limits. 🌍 Let’s not be held back by outdated prejudices: the future of light cannabis is already here, and each of us can make a difference by choosing legal, safe, and high-quality products.
Support the Future of Legal CBD with Herbify.it!
Explore our oils and a full range of CBD-rich products, carefully selected to comply with Italian and European regulations. Guaranteed quality, fast shipping, and a step towards a fairer market.
Scientific and Regulatory Sources:
Regulation (EU) 2021/2115: Standardized THC limits for industrial hemp.
Italian Ministry of Agriculture: Italian law on industrial hemp (Law No. 242/2016).
Czech Parliament (2021): THC limit of 1% for industrial hemp.
CMS Law Slovenia (2023): CBD regulation in Slovenia.
Archimede Law Firm: Legal aspects of CBD in Italy.
European Court of Justice Case C-663/18 (2020): Established that CBD cannot be classified as a narcotic if it has no psychoactive effects.
Italian Ministry of Health (2024): Ministerial decree including CBD in the Table of Narcotic Drugs, Section B.
TAR Lazio Ruling (September 10, 2024): Suspension of the ministerial decree on CBD due to lack of scientific evidence of public health risks.
WHO (World Health Organization): 2018 report on CBD safety, stating it is safe, non-addictive, and has a good therapeutic profile.
Italian Chamber of Deputies (2024): Approval of the bill banning light cannabis flowers.
Prohibition Partners (2023): Analysis of the European CBD market and its regulatory implications.